Klatskin-mimicking lesions: Still a diagnostical and therapeutical dilemma?

Hepato-Gastroenterology

Volumn 58, Issue 106, 2011, Pages 265-269

  Juntermanns, Benjamin ^a   Kaiser, Gernot Maximilian ^a   Reis, Henning ^a   Saner, Fuat Hakan ^a   Radunz, Sonia ^a   Vernadakis, Spiridon ^a   Heuer, Matthias ^a   Kuehl, Hilmar ^a   Paul, Andreas ^a   Treckmann, Juergen ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Bile duct tumor; CA19 9; Hilar cholangiocarcinoma; Klatskin tumor; Klatskin mimicking lesion

Indexed keywords

CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BILE DUCT CARCINOMA; BILE DUCT DISEASE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DATA BASE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KLATSKIN TUMOR; LIVER FAILURE; LIVER HILUS; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RELIABILITY; SARCOIDOSIS; SCLEROSING CHOLANGITIS; SURGICAL MORTALITY;

ADULT; AGED; BILE DUCT NEOPLASMS; BILIRUBIN; CA-19-9 ANTIGEN; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATIC DUCT, COMMON; HUMANS; KLATSKIN'S TUMOR; MALE; MIDDLE AGED;

EID: 79958124125     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Klatskin G: Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. Am J Med 1965; 38:241-256.
2. Li J, Kuehl H, Grabellus F, Müller SP, Radunz S, Antoch G, Nadalin S, Broelsch CE, Gerken G, Paul A, Kaiser GM: Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol 2008; 98:438-443.
3. Kaiser GM, Frühauf NR, Lang H et al: Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma Hepatogastroenterology 2008; 55:1951-1954.
4. Lang H, Kaiser GM, Zöpf T, Sotiropoulos GC, Frilling A, Malago M, et al: Surgical treatment of hilar cholangiocarcinoma. Chirurg 2006; 77:325-334. (in German with English abstract)
5. Lygidakis NJ, Sgourakis GJ, Dedemadi GV, Vlachos L, Safioleas M: Long-term results following resectional surgery for Klatskin tumors. A twenty-year personal experience. Hepato-gastroenterology 2001; 48:95-101. (Pubitemid 32226078)
6. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoriois J, et al: Changing trends in the management of Klatskin tumor. Hepato-gastroenterology 2004; 51:689-696. (Pubitemid 38590942)
7. Kaiser GM, Sotiropoulos GC, Jauch KW et al: Liver transplantation for hilar cholangiocarcinoma: a german survey. Transplant Proc 2008; 40:3191-3193.
8. Lang H, Sotiropoulos GC, Kaiser GM, Molmenti EP, Malagó M, Broelsch CE: The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 2005; 7:268-272. (Pubitemid 43878473)
9. Kawasaki S, Imamura H, Kobayashi A: Results of surgical resection for patients with hilar bile duct cancer: Application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 2003; 238:84-92. (Pubitemid 38176411)
10. Pichlmayr R, Weimann A, Klempnauer J: Surgical treatment in proximal bile duct cancer. A single center experience. Ann Surg 1996; 224:628-638.
11. Neuhaus P, Jonas S, Bechstein WO: Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230:808-818.
12. Jarnagin WR, Fong Y, DeMatteo RP: Staging, resectability, and outcome in 184 patients with hilar cholangicarcinoma. Ann Surg 2001; 234:507-517.
13. Verbeek PCM, van Leeuwen DJ, de Wit LT, Reeders JW, Smits NJ, Bosma A, Huibregtse K, van der Heyde MN: Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 1992; 112:866-871.
14. Gerhards MF, Vos P, van Gulik TM, Rauws EA, Bosma A, Gouma DJ: Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg 2001; 88:48-51. (Pubitemid 32066056)
15. Knoefel WT, Prenzel KL, Peiper M, Hosch SB, Gundlach M, Eisenberger CF, Strate T, Scheunemann P, Rogiers X, Izbicki JR: Klatskin tumors and Klatskin mimicking lesions of the biliary tree. Eur J Surg Oncol 2003; 29:658-661. (Pubitemid 37236286)
16. Ni XG, Bai, XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P: The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur J Surg Oncol. 2005; 31:164-169. (Pubitemid 40214752)
17. Gores GJ: Early detection and treatment of cholangiocarcinoma. Liver Transpl 2000; 6:30-34.
18. Laulu S, Roberts W: Performance characteristics of five automated CA19.9 assays. Am J Clin Pathol 2007; 127:436-440.
19. Singh Saluja S, Sharma R, Pal S, Sahni P, Kanti Chattopadhyay T: Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: A prospective study. HPB (Oxford) 2007; 9:373-382. (Pubitemid 47604639)
20. Robertson A, Davidson B: Mirizzi syndrome complicating an anomalous biliary tract: a novel cause of a hugely elevated CA19.9. Eur J Gastroenterol Hepatol 2007; 19:167-169. (Pubitemid 46204336)
21. Toomey DP, Swan N, Torreggiani W, Conlon KC: Autoimmune pancreatitis: medical and surgical management. JOP 2007; 8:335-343. (Pubitemid 46876794)
22. Murray M, Burton F, Bisceqlie A: Markedly elevated serum CA19.9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis. J Clin Gastroenterol 2007; 41:115-117. (Pubitemid 46045680)
23. Uygur-Bayramicli O, Dabak R, Orbay E, Dolapcioglu C, Sargin M, Kilicoglu G et al: Type 2 diabetes mellitus and CA19.9 levels. World J Gastroenterol 2007; 13:5357-5359.